Travere Therapeutics Stock Performance
as on September 29, 2026 at 6:59 am IST
Day's Low
Day's High
$58.71$61.75
4.66%
Downside
0.28%
Upside
52 Week's Low
52 Week's High
$22.06$68.7364.18%
Downside
11.61%
Upside
Travere Therapeutics share price movements today
- Previous Close
- $59.44
- Open
- $59.05
- Volume
- 924.9K
- Market Cap
- $5.5B
- Day's Low - High
- $58.71 - $61.75
- 52 Week Low - High
- $22.06 - $68.73
Travere Therapeutics Historical Returns
- 1 Month Return
- -9.49 %
- 3 Month Return
- + 1 %
- 1 Year Return
- + 134.94 %
- 3 Year Return
- + 561.92 %
- 5 Year Return
- + 148.08 %
Travere Therapeutics Stock Fundamentals & Key Indicators
Check Travere Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$5.5B
EPS (TTM)
-0.72
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-132.09
Industry PE ratio
-12.67
PEG Ratio
1.1541470104041434
EBITDA
1.5M
Revenue (TTM)
591.3M
Profit Margin
94.41%
Return On Equity TTM
-55.79%
Travere Therapeutics Stock Valuation
Track how Travere Therapeutics P/E has moved over time to understand its valuation trends.
Travere Therapeutics in the last 5 years
Lowest (-68.23x)
December 31, 2025
Today (-68.23x)
December 31, 2025
Industry (-12.67x)
December 31, 2025
Highest (-4.27x)
December 31, 2024
Today’s Price to Earnings Ratio: -68.23x
Travere Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Travere Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| StrongBuy | $5.5B | 148.08% | -132.09 | 94.41% | 0.00% | |
| StrongBuy | $43.9B | 615.18% | -23.13 | 0.00% | 0.00% | |
| Neutral | $79.4B | -48.24% | -24.92 | -12.57% | 0.00% | |
| StrongBuy | $133.4B | 189.75% | 30.38 | 86.04% | 0.00% | |
| Buy | $81.1B | 30.25% | 18.82 | 84.86% | 0.47% |
Stock Returns calculator for Travere Therapeutics Stock including INR - Dollar returns
The Travere Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Travere Therapeutics investment value today
Current value as on today
₹2,63,364
Returns
₹1,63,364
(+163.36%)
Returns from Travere Therapeutics Stock
₹1,43,399 (+143.4%)
Dollar Impact
₹19,965 (+19.96%)
Analyst Recommendation on Travere Therapeutics Stock
Based on 12 analysts
91.67%
Buy
8.33%
Hold
0.00%
Sell
Based on 12 analysts, 91.66666666666666% of analysts recommend a 'BUY' rating for Travere Therapeutics. Average target price of $75.21
Travere Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Travere Therapeutics.
What analysts predicted
18.12%UPSIDE
Target Price
$75.21
Current Price
$61.58
Analyzed by
12 Analysts
High
$90
Target
$75.21
Low
$62
Travere Therapeutics target price $75.21, a slight upside of 18.12% compared to current price of $61.58. According to 12 analysts rating.
Indian Investors' Interest in Travere Therapeutics Stock
Search interest for Travere Therapeutics Stock has decreased by -3% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Travere Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Travere Therapeutics Annual Profit & Loss
All numbers in Millions USD
Travere Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Travere Therapeutics Annual Cash Flow
All numbers in Millions USD
Travere Therapeutics News & Key Events
Today's Timeline - 21 September
Tue, 01:40 AM
-Travere Therapeutics CEO Eric Dube to step down; Bradley Campbell appointed as new CEO effective December 1, 2026.
Insights on Travere Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 6 months, TVTX stock has moved up by 118.1%
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, TVTX has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 127.19M → 169.58M (in $), with an average increase of 25.0% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -37.10M → -34.79M (in $), with an average increase of 6.6% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 712.1% return, outperforming this stock by 577.2%
About Travere Therapeutics
| Organisation | Travere Therapeutics |
| Headquarters | 3611 Valley Centre Drive, San Diego, CA, 92130, US |
| Industry | Biotechnology |
| CEO | Eric Dube |
| E-voting on shares | Click here to vote |
Key Management of Travere Therapeutics
Name | Title |
|---|---|
Dr. Eric M. Dube Ph.D. | President, CEO & Director |
Dr. William E. Rote Ph.D. | Chief Research Officer |
Mr. Peter Heerma | Chief Commercial Officer |
Dr. Jula Inrig M.D. | Executive VP, Head of Research & Development and Chief Medical Officer |
Ms. Nivi Nehra | Vice President of Corporate Communications & Investor Relations |
Ms. Angela Giannantonio | Chief People Officer |
Mr. Casey Logan | Chief Business Officer |
Mr. Christopher Cline C.F.A. | Chief Financial Officer |
Ms. Sandra Calvin | SVP & Chief Accounting Officer |
Ms. Elizabeth E. Reed J.D. | Chief Legal Officer, General Counsel & Secretary |
FAQs
What is Travere Therapeutics share price today?
Travere Therapeutics share price today is $61.58 as on at the close of the market. Travere Therapeutics share today touched a day high of $61.75 and a low of $58.71.
What is the 52 week high and 52 week low for Travere Therapeutics share?
Travere Therapeutics share touched a 52 week high of $68.73 on and a 52 week low of $22.06 on . Travere Therapeutics stock price today i.e. is closed at $61.58,which is 10.40% down from its 52 week high and 179.21% up from its 52 week low.
What is Travere Therapeutics's market capitalisation today?
Travere Therapeutics market capitalisation is $0.01T as on .
How to invest in Travere Therapeutics Stock (TVTX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Travere Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Travere Therapeutics Shares that will get you 0.0244 shares as per Travere Therapeutics share price of $61.58 per share as on September 29, 2026 at 1:29 am IST.
What is the minimum amount required to buy Travere Therapeutics Stock (TVTX) from India?
Indian investors can start investing in Travere Therapeutics (TVTX) shares with as little as ₹95.980003356934 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹959.80 in Travere Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Travere Therapeutics share’s latest price of $61.58 as on September 29, 2026 at 1:29 am IST, you will get 0.1624 shares of Travere Therapeutics. Learn more about
fractional shares .
What are the returns that Travere Therapeutics has given to Indian investors in the last 5 years?
Travere Therapeutics stock has given 148.08% share price returns and 29.13% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?